Calls for PHARMAC to fund more effective shingles vaccine with cases expected to rise due to COVID-19

Newshub

24 July 2022 - There are calls from medical experts for PHARMAC to fund a more effective vaccine for shingles, as cases of the viral infection are expected to rise as a result of COVID-19.

New research from the United States reveals that people over 50 years old who have contracted COVID-19 have an increased risk of also suffering from the painful condition.

Read Stuff article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Market access , Vaccine , COVID-19